Browsing Tag
Coya
7 posts
There Is No Cure For ALS, But Coya Therapeutics Might Have The Answer According To A New Clinical Study – Coya Therapeutics (NASDAQ:COYA)
Coya Therapeutics COYA has just reported proof of concept data from its trial for COYA 302, a new…
Coya Therapeutics: This BioPharma Company Has Some Big News To Share – Coya Therapeutics (NASDAQ:COYA)
Howard Burman, Ph.D, CEO & Chairman of Coya Therapeutics Inc COYA, was a guest on Benzinga’s All Access.…
Coya Therapeutics Enters First-Of-Its-Kind Partnership With Multi-Billion Dollar Drug Company — Why This Is a Major Moment For Drug Development – bluebird bio (NASDAQ:BLUE), Coya Therapeutics (NASDAQ:COYA)
Houston-based Coya Therapeutics COYA has entered into a partnership with Dr. Reddy’s Laboratories Ltd. RDY, a world-leading pharmaceutical…
Coya Therapeutics’ COYA 302 Treating ALS Proves Effective In Proof-Of-Concept Academic Clinical Study – Coya Therapeutics (NASDAQ:COYA)
Coya Therapeutics, Inc. COYA recently reported 48-week clinical data for its proof-of-concept open-label study in 4 ALS patients…
Coya Therapeutics Reveals Proof-of-Concept Data From Small Study With ALS Patients – Coya Therapeutics (NASDAQ:COYA)
Coya Therapeutics Inc COYA reported 48-week clinical data for its proof-of-concept open-label study in 4 Amyotrophic Lateral Sclerosis (ALS) patients…
This Company Is Focused on Treg-Enhancing Therapies – Could This Be Medicine’s Next Frontier? – Eli Lilly (NYSE:LLY), Coya Therapeutics (NASDAQ:COYA)
Texas-based biotech company, Coya Therapeutics COYA, is positioning itself as a leader in a promising area of the…
Houston-Based Coya Therapeutics To Present Results From ALS Clinical Study Data For Its Investigational Biologic Combination at the 2023 MDA Clinical & Scientific Conference in Dallas – Coya Therapeutics (NASDAQ:COYA)
Coya Therapeutics, Inc. COYA recently announced the presentation of results from an academic clinical study in patients with Amyotrophic…